For 2022, 216 508 confirmed cases of chlamydia infection were reported in 27 EU/EEA countries, with a crude notification rate of 88 cases per 100 000 population.
In 2022, 69 confirmed congenital syphilis cases were reported from 14 EU/EEA countries, while 11 other countries reported zero cases. For 2021, 55 cases were reported by 11 countries out of 24 contributing data.
Genetic and antigenic characterization data generated at the Worldwide Influenza Centre for viruses with collection dates after 31 January 2023 until 31 August 2023 informed the WHO influenza vaccine composition meeting (VCM) in September 2023 when recommendations were made for the southern hemisphere (SH) 2024 influenza season.
Measles cases are expected to continue increasing in the EU/EEA in the coming months due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries.
In 2023, significant increases in the number of measles cases and outbreaks were observed globally, including in 40 of the 53 countries of the European region, and in at least ten EU/EEA countries.